methylnitrosourea has been researched along with docetaxel anhydrous in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bliukhterova, NV; Fomina, MM; Korman, DB; Ostrovskaia, LA; Rykova, VA | 1 |
| Gorbunova, VA; Kuz'minov, AE; Naskhletashvili, DR | 1 |
| Blanc, C; Bougnoux, P; Chauvin, L; Chevalier, S; Domingo, I; Goupille, C; Guimaraes, C; Mahéo, K; Pinault, M | 1 |
1 review(s) available for methylnitrosourea and docetaxel anhydrous
| Article | Year |
|---|---|
[Combination chemotherapy with newly-developed cytostatics for disseminated small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Cisplatin; Clinical Trials, Phase II as Topic; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Glycosides; Humans; Irinotecan; Lung Neoplasms; Male; Methylnitrosourea; Middle Aged; Taxoids; Treatment Outcome | 2007 |
2 other study(ies) available for methylnitrosourea and docetaxel anhydrous
| Article | Year |
|---|---|
[Taxotere and methylnitrosourea: experimental appraisal of combination chemotherapy].
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Drug Synergism; Leukemia P388; Male; Methylnitrosourea; Mice; Paclitaxel; Survival Analysis; Taxoids; Treatment Outcome | 1999 |
Long chain n-3 polyunsaturated fatty acids increase the efficacy of docetaxel in mammary cancer cells by downregulating Akt and PKCε/δ-induced ERK pathways.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Docetaxel; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Neoplasm; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Mammary Neoplasms, Experimental; Methylnitrosourea; Phosphorylation; Protein Kinase C-delta; Protein Kinase C-epsilon; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; RNA Interference; Signal Transduction; Taxoids; Time Factors; Transfection; Tumor Burden | 2016 |